Nordson Corporation (NDSN) Q3 2026: Advanced Technology Segment Drives 28% Sales Surge and Backlog Jumps 35%
Nordson delivered record quarterly sales and earnings, fueled by broad-based organic growth and operational leverage across all segments. The Advanced Technology Solutions (ATS) segment notably outperformed with a 28% sales increase, underpinning a 35% backlog expansion signaling sustained demand momentum. Management raised full-year guidance, reflecting confidence in continued profitable growth supported by innovation and disciplined capital allocation.
Summary
- Backlog Expansion Signals Sustained Demand: Broad-based 35% backlog growth across all segments underpins strong revenue visibility.
- Operational Excellence Maintains Margins: Record EBITDA margins held steady at 32%, reflecting disciplined cost management amid inflationary pressures.
- Strategic Growth Prioritization: Management emphasizes growth in high-potential segments with balanced capital deployment including M&A and shareholder returns.
Business Overview
Nordson Corporation is a precision technology company specializing in differentiated products and solutions across three major segments: Industrial Precision Solutions (IPS), Medical and Fluid Solutions (MFS), and Advanced Technology Solutions (ATS). The company generates revenue primarily through sales of equipment, consumables, and aftermarket parts, serving diverse end markets including industrial, medical, electronics, and semiconductor industries.
Performance Analysis
Nordson achieved record third quarter sales of $818 million, representing a 10% increase year-over-year, driven by a robust 12% organic growth across all segments. The ATS segment led growth with a 28% sales increase, fueled by 31% organic expansion in electronics dispense and test and inspection product lines, reflecting strong semiconductor and electronics demand. Medical and Fluid Solutions posted a 5% sales increase, with organic growth near 11%, driven by engineered fluid solutions and medical product lines despite a divestiture impact. Industrial Precision Solutions grew 5%, with a 3% organic increase supported by packaging and industrial coatings demand.
Profitability remained strong with record EBITDA of $262 million, maintaining a 32% margin consistent with prior year, evidencing effective inflation management and operational leverage. Adjusted earnings per share reached a record $3.25, up 19% year-over-year. Free cash flow generation was robust at $237 million, with a 144% conversion rate of net income excluding non-cash items, enabling debt reduction and capital returns.
- Segment Profitability Maintained: ATS EBITDA margin expanded to 30%, up from 24% last year, driven by operational improvements and volume leverage.
- Balanced Growth Across Portfolio: MFS and IPS segments delivered steady margin performance and organic growth aligned with long-term targets.
- Strong Cash Flow Supports Strategic Flexibility: Net debt reduced with leverage ratio at 1.7 times, preserving capacity for acquisitions and shareholder returns.
Overall, Nordson's results demonstrate the effectiveness of its Ascend strategy and NBS Next growth framework in capitalizing on market opportunities while preserving margin discipline and generating strong cash flow.
Executive Commentary
"The strong momentum of the first half continued through the third quarter, delivering results above the high-end of our most recent earnings guidance. The team’s strong execution of the Ascend Strategy, combined with our diversified portfolio, differentiated precision technology and operational excellence, positioned us to deliver record sales in all three segments while maintaining our best-in-class margin performance."
Sundaram Nagarajan, President and Chief Executive Officer
"We delivered another quarter of fantastic record results. Each of our segments delivered record third quarter sales and strong organic growth. EBITDA margins remain strong and cash conversion is a continuing strength, reflecting solid earnings quality and disciplined working capital management."
Dan Hopgood, Executive Vice President and Chief Financial Officer
Strategic Positioning
1. Portfolio Diversification Enables Resilient Growth
Nordson’s diversified portfolio spans industrial, medical, and advanced technology markets, with approximately 60% recurring revenue from aftermarket parts and consumables. Over 50% of revenue is derived from growth end markets such as semiconductors, electronics, and medical, reducing cyclicality and enhancing stability. This balance supports consistent organic growth and margin resilience.
2. Ascend Strategy and NBS Next Framework Drive Execution
The company’s decentralized division-led approach under the NBS Next framework focuses on prioritizing top market opportunities, products, and customers. This disciplined execution model enables Nordson to maximize growth potential while maintaining operational excellence and margin discipline, as evidenced by sustained EBITDA margins and record earnings.
3. Advanced Technology Solutions Positioned at Cycle Peak
ATS is currently experiencing peak demand with 30% organic growth in the quarter. Management anticipates a transition to mid-single-digit growth aligned with long-term targets in fiscal 2027, reflecting a normalization from cycle highs. The segment benefits from strong semiconductor and electronics end market exposure, with future upside potential from North American chip manufacturing infrastructure investments yet to materialize.
4. Capital Allocation Balances Growth and Shareholder Returns
Nordson maintains a balanced capital allocation strategy, investing in organic growth projects, opportunistic M&A, and shareholder returns through dividends and share repurchases. With a leverage ratio of 1.7 times and robust free cash flow, the company retains flexibility to pursue strategic acquisitions that meet its financial and strategic criteria, particularly in medical and test and inspection markets.
5. Operational Excellence Mitigates Inflationary Pressures
Despite ongoing inflationary challenges including freight and commodity costs, Nordson has managed to hold EBITDA margins steady through price-cost management and operational improvements. The company’s ability to maintain best-in-class margins while growing revenue underscores its competitive advantage and operational discipline.
Key Considerations
Nordson’s Q3 performance reflects a well-executed growth strategy amid a complex macroeconomic environment. Investors should consider the following:
- Backlog as a Leading Indicator: The 35% backlog growth provides strong visibility into future revenue, particularly in ATS and medical segments.
- Segment Growth Divergence: ATS outperformance contrasts with steady, moderate growth in IPS, highlighting portfolio balance but also dependency on cyclical semiconductor demand.
- Margin Stability Amid Inflation: Maintaining EBITDA margins at 32% despite inflationary pressures is a testament to pricing power and cost control.
- M&A Discipline: Focus on bolt-on acquisitions that enhance core franchises, with ongoing pipeline activity but no large deals announced yet.
- Geographic Exposure: Asia Pacific contributed 24% organic growth, reflecting strong regional demand, while Americas and Europe showed steady growth.
Risks
Risks include potential demand volatility in semiconductor and electronics markets impacting ATS, inflationary cost pressures that could compress margins if not managed, and geopolitical uncertainties affecting supply chains and currency translation. Additionally, the timing and success of M&A integration remain execution risks.
Forward Outlook
For Q4 2026, Nordson expects continued strong demand with backlog up 35% year-over-year and assumes stable foreign exchange rates. The company raised full-year sales guidance to a range of $3.035 billion to $3.075 billion and adjusted earnings per share guidance to $11.80 to $12.00, reflecting confidence in sustained organic growth and operational execution.
- Sales expected between $3.035 billion and $3.075 billion for full year 2026
- Adjusted earnings per diluted share guidance raised to $11.80 to $12.00
Management highlighted that order momentum, particularly in ATS and medical segments, remains robust, and that operational initiatives continue to support margin and cash flow strength.
Takeaways
Nordson’s Q3 results underscore its position as a precision technology leader with a diversified portfolio and strong execution capabilities. Key takeaways include:
- Robust Demand and Backlog Growth: The 35% backlog increase across segments provides strong revenue visibility and supports raised guidance.
- Operational Discipline Preserves Margins: Despite inflation and geopolitical pressures, Nordson maintains best-in-class EBITDA margins through pricing and efficiency.
- Strategic Focus on Growth Segments: ATS and medical segments are key growth drivers, with ATS at cycle peak and medical normalizing toward long-term targets.
Conclusion
Nordson delivered a record third quarter with strong organic growth and margin stability, driven by its diversified portfolio and disciplined execution. The company’s raised guidance and backlog expansion signal confidence in continued profitable growth, supported by strategic capital allocation and operational excellence.
Industry Read-Through
Nordson’s results highlight the sustained strength in semiconductor and medical technology markets, reinforcing the importance of precision technology providers with diversified end market exposure. The company’s ability to maintain margins amid inflationary pressures offers a benchmark for peers navigating similar cost challenges. Additionally, the robust backlog growth signals ongoing capital investment cycles in electronics and medical equipment sectors, suggesting continued demand for precision dispensing and inspection technologies across the industry.